Granules Q1 net jumps 34% to ₹111.4 crore

July 17, 2020 10:43 pm | Updated 10:43 pm IST - HYDERABAD

Drugmaker Granules India has reported a consolidated net profit of ₹111.44 crore for the quarter ended June 30, an increase of 34% from the year-earlier period.

Revenue from operations at ₹735.59 crore was 24% higher, while total income increased 24.13% to ₹741.22 crore.

Operational excellence, a vigilant watch over margins through optimisation of the product mix, increased capacities and optimal capacity utilisation contributed to the performance, CMD Krishna Prasad Chigurupati said. North America and Europe markets contributed to 71% of revenues.

“Our long-term investments in backward and forward integration from APIs (active pharmaceutical ingredients) to FDs (finished dosages) are delivering expected results as demonstrated by new product launches and increase in market share of our existing products,” he said in a release.

The company has declared an interim dividend of ₹0.25 per equity share of ₹1 each.

Granules India shares advanced 7.36% to close at ₹264.05 apiece on the BSE on Friday.

On the voluntarily recall of diabetes drug Metformin Hydrochloride Extended-Release tablets USP, 750 mg, in the U.S. market, initiated by wholly owned subsidiary Granules Pharmaceuticals Inc. recently, the release said a provision of a little over ₹15 crore ($2 million) has been made during the quarter towards the impact.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.